Financials
Financial year 2025
Fair Genomics from Ukkel, company number BE0735621472, closed financial year 2025 with a result of € -38,618 after tax. For that financial year Fair Genomics recorded a gross margin of € 48,620 and equity of € 52,579. Compared with financial year 2024, the result moved from € 16,587 to € -38,618. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
€ 52,579
▼ 42% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -38,618
▼ still € 16,587 profit in 2024
Profit after tax over the fiscal year.
€ 17,683
▲ € 14,250 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 47,529.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 66,576
▲ 92% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,294
▼ 40% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 42,504
▲ € 39,059 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,535
▲ 98% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 21,020 | € 58,087 | € 77,343 | € 48,620 | ▼ 37% |
| Profit after taxes | € 13,202 | € 21,725 | € 16,587 | € -38,618 | ▼ € 55,205 |
| Equity | € 52,885 | € 74,610 | € 91,197 | € 52,579 | ▼ 42% |
| Total debts | € 53,362 | € 49,335 | € 14,727 | € 62,664 | ▲ € 47,937 |
| Cash | € 5,849 | € 3,874 | € 3,433 | € 17,683 | ▲ € 14,250 |
| Retained profit | € 47,835 | € 69,560 | € 86,147 | € 47,529 | ▼ 45% |
| Balance sheet total | € 106,247 | € 123,945 | € 105,924 | € 115,243 | ▲ 9% |
Key figures of Fair Genomics, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Fair Genomics?
What happened at Fair Genomics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 38,618 (▼ € 55,205 vs 2024). filed late Source: NBB ↗
- New establishment in Ukkel. KBO
- Romain Alderweireldt became a director. NBB
- Fondation 101 Génomes Fondation privée became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 13,202 profit in 2022 to € 38,618 loss in 2025.
Paid € 11,415 in corporate taxes since 2022.
Best year ever: 2023, with € 21,725 profit.
A new publication or filing at Fair Genomics? We notify you, reason included.
Follow Fair GenomicsDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Fair Genomics are Romain Alderweireldt and Fondation 101 Génomes Fondation privée. Romain Alderweireldt is also behind ALDROM.
Directors
According to the 2025 annual accounts
since 2019
Fondation 101 Génomes Fondation privée
Administrateur Statutaire · represented by Michel Verboogen
since 2019
Establishments
Establishment units
Physical locations of this company
Sumatralaan 6
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
OVH, FR
DNS
OVH DNS
Domain
Domain
fairgenomics.com
Registered
2019-08-09
Registrar
OVH, SAS
Expires
2026-08-09
Website info
Features
Security
Network
Details
- Company number
- 0735.621.472
- VAT number
- BE 0735.621.472
- Registered office
- Sumatralaan 6, 1180 Ukkel
- Names & denominations
- Fair Genomics · FairGX
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 October 2019
- Peppol
- Active · Active since 31 Dec 2025
- Contact
- fairgenomics.com [email protected]
- Activities · NACE
Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Gegevensverwerking, webhosting en aanverwante activiteiten
Beheer van computerfaciliteiten
Overige diensten op het gebied van informatietechnologie en computer
Activiteiten van webportalen
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
+2